Shuttle Pharma Signs $10M Deal to Acquire AI Drug Discovery Platform Molecule.ai

Shuttle Pharmaceuticals announces letter of intent to acquire Molecule.ai, an AI-powered platform transforming drug discovery through machine learning and autonomous workflows.